Search

everythinglearnresearchcommunity

for

Search:↓

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Targeted cancer therapies often cause serious skin problems that need careful management.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Oncogenic melanocyte stem cells can develop into melanoma similar to human cases.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Some medications can cause acne, and stopping these drugs is the main treatment.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Cancer treatments often cause hair loss, and more research is needed to prevent and treat it.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.

Certain drugs may cause vitiligo, so patients should be monitored.

A rare hair disorder with multiple hairs from one follicle was found on a patient's abdomen.

Keratosis pilaris is a common skin condition causing a bumpy texture, sometimes linked to other diseases, with various treatments available.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

The method accurately measures Minoxidil in drugs and is reliable for routine use.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

Chemotherapy often causes hair loss in cancer patients, affecting their mental health, but scalp cooling can help prevent it.